Clinical Trial Update: Study to Determine Safety and Dosage of OPTISON in Pediatric Participants [Phase 4]

View source ↗

Summary

Phase 4 trial results update evaluating safety and dosing of OPTISON in pediatric participants undergoing transthoracic echocardiography, including those with s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Structural Heart Disease

Drugs mentioned

• Optison

Snippet

Sponsor: GE Healthcare | Conditions: Transthoracic Echocardiography, Suspected or Known Structural or Functional Cardiac Abnormality | Phase 4 | Status: COMPLETED | Results posted: 2024-05-17